Literature DB >> 29986188

Syntheses, antiviral activities and induced resistance mechanisms of novel quinazoline derivatives containing a dithioacetal moiety.

Dandan Xie1, Jing Shi1, Awei Zhang1, Zhiwei Lei1, Guangcheng Zu1, Yun Fu1, Xiuhai Gan1, Limin Yin1, Baoan Song2, Deyu Hu3.   

Abstract

A series of novel quinazoline derivatives containing a dithioacetal moiety were designed and synthesized, and their structures were characterized by 1H nuclear magnetic resonance, 13C nuclear magnetic resonance, and high-resolution mass spectrometry. Bioassay results indicated that compound 4b exhibited remarkable protective activity against cucumber mosaic virus (CMV, EC50 = 248.6 μg/mL) and curative activity against potato virus Y (EC50 = 350.5 μg/mL), which were better than those of ningnanmycin (357.7 μg/mL and 493.7 μg/mL, respectively). Moreover, compound 4b could increase the chlorophyll content in plants, improve photosynthesis, and effectively induce tobacco anti-CMV activity.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiviral activity; Cucumber mosaic virus; Dithioacetal moiety; Induced resistance mechanism; Quinazoline derivatives

Mesh:

Substances:

Year:  2018        PMID: 29986188     DOI: 10.1016/j.bioorg.2018.06.026

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  3 in total

1.  Synthesis and Bioactivity of Novel Sulfonate Scaffold-Containing Pyrazolecarbamide Derivatives as Antifungal and Antiviral Agents.

Authors:  Zhi-Wei Lei; Jianmei Yao; Huifang Liu; Chiyu Ma; Wen Yang
Journal:  Front Chem       Date:  2022-06-22       Impact factor: 5.545

2.  Synthesis, X-ray Structure, Hirshfeld, DFT and Biological Studies on a Quinazolinone-Nitrate Complex.

Authors:  Eman M Fathalla; Mezna Saleh Altowyan; Jörg H Albering; Assem Barakat; Morsy A M Abu-Youssef; Saied M Soliman; Ahmed M A Badr
Journal:  Molecules       Date:  2022-02-06       Impact factor: 4.411

3.  Facile synthetic approach towards vasorelaxant active 4-hydroxyquinazoline-4-carboxamides.

Authors:  Marian N Aziz; Siva S Panda; ElSayed M Shalaby; Nehmedo G Fawzy; Adel S Girgis
Journal:  RSC Adv       Date:  2019-09-10       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.